PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723)

Iwamoto, F; Tanguturi, S; Desai, A; Nayak, L; Uhlmann, E; Wang, T; Lustig, R; Hertan, L; Bagley, S; Hayden, J; Laforest-Roys, C; Muzikansky, A; McCluskey, C; Chukwueke, U; McFaline-Figueroa, JR; Lee, E; Wen, PY; Reardon, D

NEURO-ONCOLOGY, 2022; 24 (): 63